Top Stories
New drug brings new risks for insurers
As litigation relating to weight loss drugs grows in the US, manufacturers are becoming increasingly subject to claims of personal injury and allegations that they knowingly failed to warn consumers of side effects
Re/insurers grapple with 'hard-to-predict' PFAS problem
PFAS could create a tidal wave of litigation, but not enough is known about the science and the law to say if these ‘forever chemicals’ are the next asbestos
Hot Topics
Making complex issues simple
Focusing on what matters to the market, understanding the forces that are shaping the industry
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to [email protected].
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.